Aperio Group, LLC - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 168 filers reported holding NEKTAR THERAPEUTICS in Q3 2015. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.

Quarter-by-quarter ownership
Aperio Group, LLC ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q4 2020$1,358,000
+6.6%
79,921
+4.1%
0.00%0.0%
Q3 2020$1,274,000
-24.7%
76,804
+5.2%
0.00%
-33.3%
Q2 2020$1,692,000
+59.5%
73,038
+22.9%
0.01%
+20.0%
Q1 2020$1,061,000
+9.0%
59,405
+31.8%
0.01%
+66.7%
Q4 2019$973,000
+42.9%
45,082
+20.6%
0.00%0.0%
Q3 2019$681,000
-56.5%
37,380
-15.2%
0.00%
-50.0%
Q2 2019$1,567,000
+14.5%
44,069
+8.3%
0.01%0.0%
Q1 2019$1,368,000
+13.2%
40,709
+10.8%
0.01%0.0%
Q4 2018$1,208,000
-47.7%
36,730
-3.1%
0.01%
-40.0%
Q3 2018$2,310,000
+17.7%
37,898
-5.7%
0.01%
+11.1%
Q2 2018$1,963,000
-65.8%
40,194
-25.5%
0.01%
-69.0%
Q1 2018$5,736,000
+92.7%
53,985
+8.3%
0.03%
+93.3%
Q4 2017$2,976,000
+185.1%
49,830
+14.6%
0.02%
+150.0%
Q3 2017$1,044,000
+23.3%
43,485
+0.3%
0.01%
+20.0%
Q2 2017$847,000
-7.6%
43,347
+11.0%
0.01%
-16.7%
Q1 2017$917,000
+100.7%
39,057
+4.7%
0.01%
+100.0%
Q4 2016$457,000
-36.0%
37,305
-10.2%
0.00%
-40.0%
Q3 2016$714,000
+85.9%
41,553
+53.9%
0.01%
+66.7%
Q2 2016$384,000
+0.5%
27,004
-2.9%
0.00%0.0%
Q1 2016$382,000
-22.8%
27,814
-5.4%
0.00%
-40.0%
Q4 2015$495,000
+121.0%
29,395
+43.5%
0.01%
+150.0%
Q3 2015$224,000
+28.0%
20,483
+46.4%
0.00%0.0%
Q2 2015$175,00013,9880.00%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q3 2015
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 1,828,400$89,281,0006.61%
Cormorant Asset Management, LP 1,500,000$73,245,0005.42%
Camber Capital Management LP 2,000,000$97,660,0003.76%
Rhenman & Partners Asset Management AB 617,652$30,160,0003.09%
BRIDGER MANAGEMENT, LLC 1,134,414$55,393,0003.00%
First Light Asset Management, LLC 374,251$18,275,0002.84%
Gs Investments, Inc. 54,000$2,636,820,0001.97%
SABBY MANAGEMENT, LLC 241,922$11,813,0001.82%
QUANTRES ASSET MANAGEMENT Ltd 50,000$2,441,0001.41%
Tibra Equities Europe Ltd 173,183$8,457,0001.27%
View complete list of NEKTAR THERAPEUTICS shareholders